Zacks Research Comments on Itron’s Q2 Earnings (NASDAQ:ITRI)

Itron, Inc. (NASDAQ:ITRI) – Stock analysts at Zacks Research reduced their Q2 2027 earnings estimates for Itron in a research report issued on Tuesday, August 18th. Zacks Research analyst Team now forecasts that the scientific and technical instruments company will post earnings per share of $1.67 for the quarter, down from their previous forecast of $2.21. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Itron’s current full-year earnings is $6.40 per share. Zacks Research also issued estimates for Itron’s Q4 2027 earnings at $1.23 EPS and FY2028 earnings at $8.02 EPS.

Itron (NASDAQ:ITRI) last posted its quarterly earnings data on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.29 by $0.30. Itron had a net margin of 11.90% and a return on equity of 19.26%. The business had revenue of $562.90 million for the quarter, compared to analyst estimates of $566.34 million. During the same quarter in the previous year, the firm posted $1.62 earnings per share. Itron’s quarterly revenue was down 7.2% on a year-over-year basis. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS.

ITRI has been the subject of several other research reports. TD Cowen decreased their price target on Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Roth Capital reiterated a “buy” rating and issued a $136.00 price objective on shares of Itron in a report on Wednesday, April 29th. Robert W. Baird set a $125.00 target price on Itron in a research report on Wednesday, July 29th. Seaport Research Partners restated a “buy” rating and set a $150.00 target price on shares of Itron in a research note on Wednesday, July 29th. Finally, Stephens reaffirmed an “overweight” rating and set a $130.00 price target on shares of Itron in a report on Wednesday, May 20th. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $131.33.

Itron Stock Performance

Shares of ITRI stock opened at $98.86 on Thursday. The company has a market capitalization of $4.33 billion, a price-to-earnings ratio of 16.50, a price-to-earnings-growth ratio of 0.79 and a beta of 1.30. The company has a debt-to-equity ratio of 0.96, a quick ratio of 2.29 and a current ratio of 2.75. Itron has a one year low of $77.77 and a one year high of $142.00. The company’s 50-day moving average is $89.77 and its 200 day moving average is $90.11.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of ITRI. EverSource Wealth Advisors LLC increased its holdings in shares of Itron by 25.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after buying an additional 81 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of Itron by 29.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock valued at $41,000 after buying an additional 101 shares in the last quarter. Impact Partnership Wealth LLC lifted its holdings in shares of Itron by 4.7% in the 1st quarter. Impact Partnership Wealth LLC now owns 2,661 shares of the scientific and technical instruments company’s stock valued at $239,000 after acquiring an additional 119 shares during the last quarter. Xponance LLC grew its position in Itron by 3.2% in the fourth quarter. Xponance LLC now owns 3,877 shares of the scientific and technical instruments company’s stock worth $360,000 after acquiring an additional 120 shares in the last quarter. Finally, Private Trust Co. NA grew its position in Itron by 112.4% in the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock worth $25,000 after acquiring an additional 145 shares in the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, SVP Donald L. Reeves III sold 319 shares of the stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $26,914.03. Following the completion of the sale, the senior vice president directly owned 29,100 shares of the company’s stock, valued at $2,455,167. This represents a 1.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Joan S. Hooper sold 442 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $37,291.54. Following the sale, the chief financial officer directly owned 117,478 shares in the company, valued at approximately $9,911,618.86. This represents a 0.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 2,035 shares of company stock valued at $171,731. 1.77% of the stock is owned by corporate insiders.

Itron News Summary

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Zacks raised several earnings estimates. The firm increased its FY2026 EPS forecast to $6.35 from $5.97, lifted Q4 2026 EPS to $1.72 from $1.65, and raised FY2027 EPS to $5.90 from $5.86. It also made smaller increases to Q3 2026, Q1 2027, Q3 2027 and Q1 2028 estimates, suggesting modest confidence in Itron’s near-term operating performance. MarketBeat Itron analyst estimates
• Positive Sentiment: Itron was added to multiple Zacks Strong Buy lists. On August 19, the company appeared on Zacks’ #1-ranked momentum, value and general Strong Buy lists. These designations may attract additional investor interest, particularly because ITRI trades below its 52-week high and near its 50-day and 200-day moving averages. Zacks momentum stocks article
• Neutral Sentiment: Zacks continues to rate Itron Hold. Despite the estimate increases and Strong Buy list appearances, the firm has not formally upgraded its rating. The current-year consensus EPS estimate is approximately $6.40, broadly consistent with the revised FY2026 forecast. Itron’s latest reported quarter also showed an EPS beat, but revenue declined 7.2% year over year.
• Negative Sentiment: Some longer-term estimates were reduced. Zacks cut its Q2 2027 EPS forecast to $1.67 from $2.21 and lowered FY2028 EPS to $8.02 from $8.86. It also reduced Q2 2028 EPS to $1.87 from $1.97, tempering the bullish impact of the nearer-term upward revisions. GuruFocus Itron valuation article

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.